Paraneoplastic neuropathy: Wide-ranging clinicopathological manifestations

Current Opinion in Neurology

Volumn 24, Issue 5, 2011, Pages 504-510

  Koike, Haruki ^a   Tanaka, Fumiaki ^a   Sobue, Gen ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Autonomic neuropathy; chronic inflammatory demyelinating polyneuropathy; ganglionopathy; Guillain Barr syndrome; small fiber neuropathy

Indexed keywords

AUTOANTIBODY; CHORIONIC GONADOTROPIN; FLUORODEOXYGLUCOSE F 18; IMMUNOGLOBULIN;

AUTONOMIC NEUROPATHY; CANCER SCREENING; CANCER THERAPY; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; MEDICAL LITERATURE; NEUROPATHY; PARANEOPLASTIC NEUROPATHY; PLASMAPHERESIS; POSITRON EMISSION TOMOGRAPHY; REVIEW; SENSORY NEUROPATHY;

AUTOANTIBODIES; HUMANS; PARANEOPLASTIC POLYNEUROPATHY;

EID: 80052499486     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0b013e32834a87b7     Document Type: Review

References (68)

1. Krarup C, Crone C. Neurophysiological studies in malignant disease with particular reference to involvement of peripheral nerves. J Neurol 2002; 249:651-661. (Pubitemid 34651744)
2. Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004; 75:1135-1140. (Pubitemid 39005770)
3. Wells EM, Dalmau J. Paraneoplastic neurologic disorders in children. Curr Neurol Neurosci Rep 2011; 11:187-194.
4. Giometto B, Grisold W, Vitaliani R, et al. Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers. Arch Neurol 2010; 67:330-335.
5. Demarquay G, Didelot A, Rogemond V, et al. Facial pain as first manifestation of anti-Hu paraneoplastic syndrome. J Headache Pain 2010; 11:355-357.
6. Ducray F, Graus F, Vigliani MC, et al. Delayed onset of a second paraneoplastic neurological syndrome in eight patients. J Neurol Neurosurg Psychiatry 2010; 81:937-939.
7. Dalmau J, Graus F, Rosenblum MK, Posner JB. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine (Baltimore) 1992; 71:59-72.
8. Graus F, Keime-Guibert F, Reñe R, et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 2001; 124:1138-1148. (Pubitemid 32510382)
9. Giglio P, Gilbert MR. Neurologic complications of cancer and its treatment. Curr Oncol Rep 2010; 12:50-59.
10. Windebank AJ, Grisold W. Chemotherapy-induced neuropathy. J Peripher Nerv Syst 2008; 13:27-46. (Pubitemid 351393018)
11. Bahl A, Chakrabarty B, Gulati S, et al. Acute onset flaccid quadriparesis in pediatric non-Hodgkin lymphoma: vincristine induced or Guillain-Barré syndrome? Pediatr Blood Cancer 2010; 55:1234-1235.
12. Beydoun SR, Shatzmiller RA. Chronic immune-mediated demyelinating polyneuropathy in the setting of cetuximab treatment. Clin Neurol Neurosurg 2010; 112:900-902.
13. Terui K, Takahashi Y, Sasaki S, et al. Guillain-Barré syndrome mimicking acute methotrexate-associated encephalopathy in an adolescent patient with lymphoblastic lymphoma. J Pediatr Hematol Oncol 2010; 32:615-616.
14. Melguizo I, Gilbert M, Tummala S. Guillain-Barré syndrome and glioblastoma. J Neurooncol (in press).
15. Gozzard P, Maddison P. Which antibody and which cancer in which paraneoplastic syndromes? Pract Neurol 2010; 10:260-270.
16. Tajima Y, Mito Y, Sudo K. Predominant sensory ataxic neuronopathy showing marked improvement after resection of a thymoma followed by intravenous immunoglobulin therapy. Intern Med 2010; 49:2621-2625.
17. McNamara P, Costelloe L, Langan Y, Redmond J. Anti-Yo positive dorsal root ganglionopathy. J Neurol 2011; 258:519-520.
18. Ichimura M, Yamamoto M, Kobayashi Y, et al. Tissue distribution of pathological lesions and Hu antigen expression in paraneoplastic sensory neuronopathy. Acta Neuropathol 1998; 95:641-648.
19. Oki Y, Koike H, Iijima M, et al. Ataxic vs painful form of paraneoplastic neuropathy. Neurology 2007; 69:564-572. (Pubitemid 47357263)
20. Koike H, Atsuta N, Adachi H, et al. Clinicopathological features of acute autonomic and sensory neuropathy. Brain 2010; 133:2881-2896.
21. Miyazaki Y, Koike H, Ito M, et al. Acute superficial sensory neuropathy with generalized anhidrosis, anosmia, and ageusia. Muscle Nerve 2011; 43:286-288.
22. Koike H, Sobue G. Small neurons may be preferentially affected in ganglionopathy. J Neurol Neurosurg Psychiatry 2008; 79:113. (Pubitemid 351236536)
23. Mori K, Iijima M, Koike H, et al. The wide spectrum of clinical manifestations in Sjö gren's syndrome-associated neuropathy. Brain 2005; 128:2518-2534. (Pubitemid 41552938)
24. Lipton RB, Galer BS, Dutcher JP, et al. Large and small fibre type sensory dysfunction in patients with cancer. J Neurol Neurosurg Psychiatry 1991; 54:706-709.
25. Nokura K, Nagamatsu M, Inagaki T, et al. Acute motor and sensory neuronopathy associated with small-cell lung cancer: a clinicopathological study. Neuropathology 2006; 26:329-337. (Pubitemid 44086837)
26. Graber JJ, Nolan CP. Myelopathies in patients with cancer. Arch Neurol 2010; 67:298-304.
27. Antoine JC, Honnorat J, Camdessanché JP, et al. Paraneoplastic anti-CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy. Ann Neurol 2001; 49:214-221. (Pubitemid 32157997)
28. Lisak RP, Mitchell M, Zweiman B, et al.Guillain-Barré syndrome and Hodgkin's disease: three cases with immunological studies. Ann Neurol 1977; 1:72-78.
29. Hughes RA, Britton T, Richards M. Effects of lymphoma on the peripheral nervous system. J R Soc Med 1994; 87:526-530. (Pubitemid 24285563)
30. Antoine JC, Mosnier JF, Absi L, et al. Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without antionconeural antibodies. J Neurol Neurosurg Psychiatry 1999; 67:7-14. (Pubitemid 29278320)
31. Vigliani MC, Magistrello M, Polo P, et al. Risk of cancer in patients with Guillain-Barré syndrome (GBS). A population-based study. J Neurol 2004; 251:321-316.
32. Zilli T, Allal AS. Guillain-Barré syndrome as an atypical manifestation of an esophageal carcinoma. Neurol Sci 2011; 32:151-153.
33. Joint Task Force of the EFNS and the PNS. European Federation of NeurologicalSocieties/PeripheralNerve SocietyGuideline onmanagement of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-First Revision. J Peripher Nerv Syst 2010; 15:1-9.
34. Antoine JC, Mosnier JF, Lapras J, et al. Chronic inflammatory demyelinating polyneuropathy associated with carcinoma. J Neurol Neurosurg Psychiatry 1996; 60:188-190. (Pubitemid 26044193)
35. Bird SJ, Brown MJ, Shy ME, Scherer SS. Chronic inflammatory demyelinating polyneuropathy associated with malignant melanoma. Neurology 1996; 46:822-824. (Pubitemid 26099655)
36. Briani C, Vitaliani R, Grisold W, et al. Spectrum of paraneoplastic disease associated with lymphoma. Neurology 2011; 76:705-710.
37. Allen JA, Yang XJ, Sufit RL. Reversible demyelinating neuropathy associated with renal cell carcinoma. Neuromuscul Disord 2011; 21:227-231.
38. Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathies. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society-first revision. J Peripher Nerv Syst 2010; 15:185-195.
39. Lucchinetti CF, Kimmel DW, Lennon VA. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology 1998; 50:652-657.
40. Pezzimenti JF, Bruckner HW, DeConti RC. Paralytic brachial neuritis in Hodgkin's disease. Cancer 1973; 31:626-629.
41. Lachance DH, O'Neill BP, Harper CM Jr, et al. Paraneoplastic brachial plexopathy in a patient with Hodgkin's disease. Mayo Clin Proc 1991; 66:97-101.
42. Collins MP, Dyck PJ, Gronseth GS, et al. Peripheral Nerve Society Guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of nonsystemic vasculitic neuropathy: executive summary. J Peripher Nerv Syst 2010; 15:176-184.
43. Fain O, Hamidou M, Cacoub P, et al. Vasculitides associated with malignancies: analysis of sixty patients. Arthritis Rheum 2007; 57:1473-1480. (Pubitemid 350308846)
44. Younger DS, Dalmau J, Inghirami G, et al. Anti-Hu-associated peripheral nerve and muscle microvasculitis. Neurology 1994; 44:181-183. (Pubitemid 24029462)
45. Yu Z, Kryzer TJ, GriesmannGE, et al. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 2001; 49:146-154. (Pubitemid 32157990)
46. McKeon A, Lennon VA, Lachance DH, et al. Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments. Arch Neurol 2009; 66:735-741.
47. Vernino S, Sandroni P, Singer W, Low PA. Invited article: autonomic ganglia: target and novel therapeutic tool. Neurology 2008; 70:1926-1932. (Pubitemid 351684647)
48. Winston N, Vernino S. Recent advances in autoimmune autonomic ganglionopathy. Curr Opin Neurol 2010; 23:514-518.
49. Koike H, Koyano S, Morozumi S, et al. Slowly progressive autonomic neuropathy with antiganglionic acetylcholine receptor antibody. J Neurol Neurosurg Psychiatry 2010; 81:586-587.
50. Chinn JS, Schuffler MD. Paraneoplastic visceral neuropathy as a cause of severe gastrointestinal motor dysfunction. Gastroenterology 1988; 95:1279-1286.
51. Titulaer MJ, Soffietti R, Dalmau J, et al. Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force. Eur J Neurol 2011; 18:19-27.
52. Sadeghian H, Vernino S. Progress in the management of paraneoplastic neurological disorders. Ther Adv Neurol Disord 2010; 3:43-52.
53. Bannas P, Weber C, Derlin T, et al. 18F-FDG-PET/CT in the diagnosis of paraneoplastic neurological syndromes: a retrospective analysis. Eur Radiol 2010; 20:923-930.
54. McKeon A, Apiwattanakul M, Lachance DH, et al. Positron emission tomography-computed tomography in paraneoplastic neurologic disorders: systematic analysis and review. Arch Neurol 2010; 67:322-329.
55. Selva-O'Callaghan A, Grau JM, Gámez-Cenzano C, et al. Conventional cancer screening versus PET/CT in dermatomyositis/polymyositis. Am J Med 2010; 123:558-562.
56. Delforge M, Bladé J, Dimopoulos MA, et al. Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues. Lancet Oncol 2010; 11:1086-1095.
57. Sheikh SI, Amato AA. The dorsal root ganglion under attack: the acquired sensory ganglionopathies. Pract Neurol 2010; 10:326-334.
58. Dispenzieri A, Klein CJ, Mauermann ML. Lenalidomide therapy in a patient with POEMS syndrome. Blood 2007; 110:1075-1076. (Pubitemid 47267453)
59. Kuwabara S, Misawa S, Kanai K, et al. Thalidomide reduces serum VEGF levels and improves peripheral neuropathy in POEMS syndrome. J Neurol Neurosurg Psychiatry 2008; 79:1255-1257.
60. Kaygusuz I, Tezcan H, Cetiner M, et al. Bortezomib: a new therapeutic option for POEMS syndrome. Eur J Haematol 2010; 84:175-177.
61. Ohguchi H, Ohba R, Onishi Y, et al. Successful treatment with bortezomib and thalidomide for POEMS syndrome. Ann Hematol (in press).
62. Chan KH, Vernino S, Lennon VA. ANNA-3 antineuronal nuclear antibody: marker of lung cancer-related autoimmunity. Ann Neurol 2001; 50:301-311. (Pubitemid 32848732)
63. Tschernatsch M, Singh P, Gross O, et al. Anti-SOX1 antibodies in patients with paraneoplastic and nonparaneoplastic neuropathy. J Neuroimmunol 2010; 226:177-180.
64. Mutoh T, Tachi M, Yano S, et al. Impairment of Trk-neurotrophin receptor by the serum of a patient with subacute sensory neuropathy. Arch Neurol 2005; 62:1612-1615. (Pubitemid 41434569)
65. Tschernatsch M, Klotz M, Probst C, et al. Synaptophysin is an autoantigen in paraneoplastic neuropathy. J Neuroimmunol 2008; 197:81-86.
66. Durmuş H, Tüzün E, Içöz S, et al. Sensorimotor neuropathy associated with endometrioid endometrial carcinoma. Eur J Obstet Gynecol Reprod Biol 2010; 150:216-217.
67. Murakami H, Rino Y, Yamanaka S, et al. Paraneoplastic neurological syndrome in a patient with gastric cancer. Gastric Cancer 2010; 13:204-208.
68. Van Broekhoven F, de Graaf MT, Bromberg JE, et al. Human chorionic gonadotropin treatment of anti-Hu-associated paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2010; 81:1341-1344.